Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: winzer5 who wrote (13286)	2/7/2004 1:01:55 PM
From: Cal Gary	Read Replies (1) \| Respond to of 14101

Hi Winzer5 What you describe is also known as a hedge. Variations exist in other financial markets like convertible bonds/shares, warrants, equity options, other options and commodities. The opposite is when you hold financial instruments either long or short with no off-setting "guarantee" hedge, you are exposed or nake. For example in options, you can write naked puts (exposed short). As long as the "(possibly future underwriters)" are participants in the PP then they have no risk (zero) on their shorts, even if FDA approval comes during the financing. There are full hedges, half hedges or variations. Full hedge is when you know you will receive via subscription, for example, 100 shares at 1.00 at x date. And short exactly 100 shares at any price above 1.00+commish. Your profit is hedged or locked in. There are situations when "breaking one of the legs" of the hedge is advantageous that allows you to participate in a bull or bear run. Half hedges in comparison is when you know you will receive, for example, 100 shares at 1.00 at x date. And short exactly 50 shares at any price above 1.00+commish. Your profit is half hedged or partially locked in. You continue to be exposed or naked for the other half, make or lose money. In DMX's toxic financing, we have evidence that the PP participants must have some guarantee of PP participation, short millions of shares for weeks, then sign off the PP participation in the future, take delivery of PP shares and deliver to cover their shorts. Anyways, I remain DMX long and naked. Blush.

To: winzer5 who wrote (13286)	2/7/2004 11:40:54 PM
From: axial	Respond to of 14101

Winzer, that was hilarious... DIMECLONE !!? LOL! As regards the possibility of imminent FDA approval for Pennsaid, IMO insider buying - or the lack of same - tells us all we want to know about that. If you were a member of Dimethaid management, and believed there was a good possibility that FDA would approve Pennsaid soon, would you be... A - Keeping your options? B - Buying shares at this ridiculous price? Dimethaid management is doing neither. They've been using their options for income. If Dimethaid management is buying shares, they're not DMX shares. They've probably invested in a pharma with good management. If you want to see a vote of confidence in Dimethaid's management, don't look for it within the corporation. It doesn't exist. Don't look for it in that mysterious, vanishing "Analyst's Report", and don't look for it from RK's "institutional investors" who short, and sell DMX as soon as they can. "Conventional financing". Right, RK. We believe you. Millions wouldn't, but we do. Jim